University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma

Phase 2

Active, not recruiting

Conditions: Glioblastoma

Interventions: Drug: INCMGA00012
Drug: INCAGN01876
Drug: SRS
Procedure: Brain surgery

First Posted Date: 2020-01-13

Last Posted Date: 2024-03-26

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 39

Registration Number: NCT04225039

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

The Physiological Chronobiome Modified by Age, Sex and Under Evoked Conditions

Not Applicable

Active, not recruiting

Conditions: Healthy
Healthy Aging

Interventions: Other: Fatty meal to challenge the physiological chronobiome in healthy young and old

First Posted Date: 2020-01-13

Last Posted Date: 2024-01-24

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 48

Registration Number: NCT04225442

Locations: 🇺🇸
Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States

Niraparib/TTFields in GBM

Phase 2

Active, not recruiting

Conditions: Glioblastoma
Recurrent Glioblastoma
GBM

Interventions: Drug: Niraparib
Device: Optune
Procedure: Planned surgical resection

First Posted Date: 2020-01-09

Last Posted Date: 2024-02-09

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 30

Registration Number: NCT04221503

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

18F-FluorThanatrace (PET/CT) in Glioblastoma

Early Phase 1

Terminated

Conditions: Glioblastoma

Interventions: Drug: 18F-FluorThanatrace

First Posted Date: 2020-01-09

Last Posted Date: 2024-06-17

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 3

Registration Number: NCT04221061

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

RescueTEE for In-hospital Cardiac Arrest (ReTEECA Trial)

Not Applicable

Withdrawn

Conditions: ACLS
In-hospital Cardiac Arrest
Cardiac Arrest
Image Guided ACLS
Echocardiography, Transesophageal
Cardiopulmonary Arrest With Successful Resuscitation

Interventions: Diagnostic Test: Tranesophageal Echocardiography

First Posted Date: 2020-01-07

Last Posted Date: 2024-02-28

Lead Sponsor: University of Pennsylvania

Registration Number: NCT04220619

Combining Pregabalin (LYRICA®) With Lofexidine (LUCEMYRATM) to Treat OPIOID Withdrawal

Phase 2

Completed

Conditions: Opioid Withdrawal

Interventions: Drug: Pregabalin 200 MG capsules
Drug: Placebo oral tablet
Drug: Lofexidine 0.18Mg Tab

First Posted Date: 2020-01-06

Last Posted Date: 2024-08-28

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 90

Registration Number: NCT04218240

Locations: 🇺🇸
Mountain Manor Treatment Center, Baltimore, Maryland, United States
🇺🇸
Treatment Research Center, Philadelphia, Pennsylvania, United States
🇺🇸
John Mariani, New York, New York, United States

Improving Aging in Place in Subsidized Housing

Not Applicable

Completed

Conditions: Physical Disability
Physical Activity
Cognitive Impairment

Interventions: Behavioral: Independent Living Program for Affordable Housing.

First Posted Date: 2019-12-27

Last Posted Date: 2024-11-15

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 75

Registration Number: NCT04212442

Locations: 🇺🇸
St. Francis VIlla, Philadelphia, Pennsylvania, United States
🇺🇸
Casa Carmen Aponte, Philadelphia, Pennsylvania, United States
🇺🇸
Greenway Presbyterian Apartments, Philadelphia, Pennsylvania, United States

and more 10 locations

Neurocognitive Benefits of a Weight Management Program

Phase 4

Completed

Conditions: Overweight and Obesity

Interventions: Behavioral: Waitlist
Behavioral: WW (formerly Weight Watchers)

First Posted Date: 2019-12-17

Last Posted Date: 2021-07-29

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 61

Registration Number: NCT04202133

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Fecal Microbial Transplantation for the Treatment of Fecal Incontinence in Women

Phase 1

Terminated

Conditions: Fecal Incontinence

Interventions: Biological: fecal microbial transplantation (FMT)

First Posted Date: 2019-12-17

Last Posted Date: 2024-06-12

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 10

Registration Number: NCT04201821

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Diet Interventions in Psoriatic Arthritis

Not Applicable

Active, not recruiting

Conditions: Psoriatic Arthritis

Interventions: Other: Diet 1
Other: Diet 2

First Posted Date: 2019-11-29

Last Posted Date: 2024-07-12

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 90

Registration Number: NCT04180904

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇨🇦
Women's College Hospital, University of Toronto, Toronto, Ontario, Canada

Home Terms & Conditions Privacy Policy